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 I 
PREFACE 
After 3 years of hard work my PhD life is coming to an end. It has been a journey of 
intense research giving birth to a lot of challenges but certainly also professional and 
personal development.  
The groundwork for this PhD thesis was carried out at Aarhus University in 2011 
where I obtained a master degree in Biology. Looking back at my first encounter 
with a medical laboratory at the Department of Biomedicine in Aarhus I must admit 
that the last 4 years have changed the way that I understand and think biological 
science. Moreover, accepting that the title biologist does not mean “plants and 
animal expert” but simply means having an interest in exploring and explaining the 
functioning of living organisms. In my case this has so far been mostly related to 
human biology and the investigation of immunological dysfunction. The research 
experience that follows a PhD programme has given me a comprehensive 
knowledge of the scientific process from hypothesis to methodology, laboratory 
work, data analysis and presentation, which will make it easier to engage in 
scientific problem solving in the near future. More so, accepting mistakes as a part 
of this process. The ability to combine different research tools to create data suitable 
for publication has been very satisfying and I no longer have any problems with the 
title researcher, because I actually believe it suites me well.  
This Dissertation is constructed with an opening introduction followed by a brief 
description of the methodological approaches and concluded in a summarizing 
discussion. The aim of the thesis is presented through research hypotheses, which 
are further discussed in 4 scientific papers of which one of them (paper III) is a 
review that discuss findings in paper I & II. 
I would like to thank my parents and brother, Lis Carlsen, Lars Gelsing and Mikael 
Gelsing Carlsen for moral support. In addition, I would like to thank everyone 
involved in my research especially laboratory technicians Karin Skovgaard Sørensen 
and Ditte Bech Kristensen. A special thank to Supervisors Svend Birkelund and 
Gunna Christiansen. I would also like to thank the Amnon group at the La Jolla 
institute for Allergy and Immunology in San Diego for being friendly and open, 
making my three months stay as visiting researcher a worthwhile experience. 
Thomas Gelsing Carlsen 
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ABSTRACT 
The Spondyloarthritis (SpA) comprise a heterogenic group of 5 diseases in which 
immunological dysfunction give rise to a number of shared symptoms used for 
diagnosis. Most notably, these include sacroilitis, spondylitis and the presence of 
enthesitis. Treatment is a combination of anti-inflammatory drugs and exercise to 
relieve the patient from pain and risk of spinal fusion. However, as no cure is at 
hand ongoing research seeks to improve the understanding of the underlying 
mechanism responsible for SpA pathogenesis, which is also the overall objective of 
this thesis. Several hypotheses are retrieved from the literature, which since the 
discovery of the susceptibility gene HLA-B27 have moved from interest in the 
antigenic presentation of peptides to CD8+ T cells and autoimmune reactions born 
from protein homology to exploring the presence of single nucleotide 
polymorphisms (SNP) in the genotype of SpA through genome-wide association 
studies. The polygenic nature of these diseases is a challenge, as the genetic 
background of SpA seems to be significant only in combination with environmental 
stimuli such as bacterial infections.  
To target this complexity the following hypotheses were constructed 1) Anti-HSP60 
antibodies are linked to disease activity in SpA 2) IgG subclass determination of the 
Anti-HSP60 response in SpA does not support cross-reactivity 3) SNP’s in the IL-1A 
gene affect kinetics in the IL-1α response. These hypotheses have generated 3 
scientific research papers which content is outlined below. 
The first study was conducted on 82 serum samples collected from patients with 
symptoms restricted to the axial skeleton. The objective for this study was to 
investigate if a relationship between antibodies to the immunogenic heat shock 
protein 60 (HSP60) and clinical characteristics exist. Recombinant HSP60 was 
purified for human and 3 different bacteria known to trigger SpA disease. 
Furthermore, an enzyme-linked immunosorbent assay (ELISA) was established to 
determine levels of anti-HSP60 IgG subclass antibodies. The amino acid similarity 
between bacterial and human HSP60, also named molecular mimicry, has generated 
belief that cross-reactive antibodies exist with possible implication in SpA 
pathogenesis. However, our results demonstrated no significant higher levels of 
antibodies to bacterial HSP60 between SpA patients and healthy controls. Moreover, 
while antibodies against human HSP60 were associated with SpA and 
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predominantly of the IgG3 subclass, antibodies against bacterial HSP60 are 
predominantly of the IgG1 subclass. Therefore, based on the ELISA results, cross-
reaction between bacterial and human HSP60 could not be supported as a 
pathogenic mechanism for SpA disease in our study. However, a weak correlation 
between anti-human HSP60 IgG3 and one of the several disease parameters was 
demonstrated, which generated interest in conducting a follow-up study in which the 
same patients were enrolled and again asked for blood donation. 
The second study was a cohort study in which two serum samples from the same 
patient collected with a 4-year interval, were analyzed. Antibodies measured in the 
first study could now be determined over time. Hence, this study investigates the 
association between antibody levels and disease progression. Unfortunately only 39 
patients (48%) of the samples already analysed in paper I was collected. Probably 
due to the reduced number of patients participating, no correlation between disease 
parameters and antibodies was demonstrated. Again, the IgG subclass specificity for 
bacterial and human HSP60 was presented with a dominance of IgG3 for human 
HSP60 and IgG1 for bacterial HSP60 rejecting the hypothesis of cross-reactivity.  
The third study was based on the fact that polymorphisms in genes involved in 
innate immune recognition and cytokine signaling pathways have been 
demonstrated among SpA patients. Among these genes is IL-1A, which is 
considered a pro-inflammatory cytokine produced mainly by macrophages at the site 
of infection. IL-1α is synthesized as a 33 kDa precursor peptide that in mice is 
cleaved by a calpain-like protease to a nuclear-associated 16 kDa propiece and a 
secreted 17 kDa mature IL-1α peptide. It is apparent from the literature that a 
functional assay to validate the importance of SNPs in the IL-1α gene is needed. 
Therefore, we made a time-course study in which human machrophages enriched 
from peripheral blood was stimulated with a bacterial endotoxin named 
lipopolysaccharide (LPS) and stained for the propiece with a monoclonal antibody 
(MAb) generated against recombinant precursor IL-1α. Moreover, by conjugating 
the MAb to a fluorophore (FITC) we conducted a flow cytometric analysis to 
investigate the IL-1α kinetics among human monocytes. With the use of confocal 
microscopy IL-1α propiece was demonstrated to localize to the nucleus already 2 hrs 
post LPS stimulation with increased intensity at 12 and 20 hrs post LPS stimulation. 
Interestingly, a western blot analysis of LPS-stimulated human monocytes could not 
detect the propiece cleavage product. Finally, CD68 proved to be a valid marker for 
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IL-1α producing monocytes. The kinetics of IL-1α protein production followed a 
saturation curve profile while mRNA production was strongest at 4 hrs.  
 
In conclusion, the findings of this thesis have demonstrated 1) That antibodies 
against bacterial and human HSP60 are not markers for SpA disease progression. 2) 
That IgG subclass specificity exist for human (IgG3) and bacterial (IgG1) HSP60 
not supporting cross-reactivity as a pathogenic trigger in SpA disease. 3) That IL-1α 
propiece localize to the nucleus of human macrophages and increases exponentially 
over time up until 20 hrs post LPS stimulation. Based on the findings of this thesis 
the long-lived hypothesis of molecular mimicry, as a pathogenic trigger in SpA 
pathogenesis seems unlikely. Moreover, a path is set for a clinical study in which 
donors sequenced for the IL-1A gene is validated with measurements on IL-1α 
kinetics from the method developed here. This could provide important knowledge 
on a potential functional role for IL-1A SNP’s in SpA pathogenesis. 
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DANSK RESUMÉ 
Spondylartrit (SpA) omfatter en heterogen gruppe af 5 sygdomme, hvor 
immunologisk dysfunktion giver anledning til en række fælles symptomer anvendt 
til diagnosticering. Mest bemærkelsesværdigt omfatter disse sacroilitis, spondylitis 
og enthesitis. Behandling er en kombination af anti-inflammatoriske lægemidler og 
øvelser der aflaster patienten fra smerte og risiko for spinal fusion. Da der ikke 
findes en kur for SpA forsøger igangværende forskning imidlertid at forbedre 
forståelsen af den underliggende mekanisme der er ansvarlig for udviklingen af 
sygdommen. Dette er også det overordnede formål med denne afhandling. 
Adskillige hypoteser kan hentes fra litteraturen, som siden opdagelsen af 
susceptibilitetsgenet HLA-B27 er flyttet fra interesse i den antigene præsentation af 
peptider til CD8+ T-celler og autoimmune reaktioner affødt af protein homologi til 
at udforske tilstedeværelsen af enkelt nukleotid-polymorfier (SNP) i genotypen ved 
SpA patienter gennem genom-dækkende associationsstudier. Den polygeniske 
karakter af disse sygdomme er en udfordring, idet den genetiske baggrund for 
sygdom synes at være væsentlig kun i kombination med miljømæssige stimuli, 
såsom bakterielle infektioner.  
For at omfatte denne kompleksitet blev følgende hypoteser konstrueret 1) anti-
HSP60 antistoffer er forbundet med sygdomsaktivitet i SpA 2) IgG subklasse 
bestemmelse af anti-HSP60 responset støtter ikke hypotesen om krydsreaktivit ved 
SpA 3) SNP’er i IL-1A genet har indflydelse på kinetikken i IL-1α responset. Disse 
hypoteser har genereret 3 videnskabelige forskningsartikler, hvis indhold er skitseret 
nedenfor.  
Det første studie var en serologisk undersøgelse af 82 serumprøver fra patienter med 
symptomer begrænset til rygsøjlen. Målet for dette studie var at undersøge, om der 
eksisterer en sammenhæng mellem antistoffer mod det immunogene heat shock 
protein 60 (HSP60) og kliniske karakteristika for SpA diagnose. Rekombinant 
HSP60 blev oprenset for human og 3 forskellige bakterier kendt for at udløse SpA 
sygdom. Endvidere blev et enzymatisk assay (ELISA) etableret for at bestemme 
niveauer af anti-HSP60 IgG subklasse antistoffer. Aminosyre lighed mellem 
bakteriel og human HSP60, også kaldet “molecular mimicry”, har genereret tro på, 
at kryds-reaktive antistoffer kan være involveret i SpA patogenesen. Men vores 
resultater viste ingen signifikant højere niveauer af antistoffer til bakteriel HSP60 
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mellem SpA patienter og raske kontroller. Desuden, var antistoffer mod human 
HSP60, forbundet med SpA, overvejende af IgG3-underklassen, hvorimod 
antistoffer mod bakteriel HSP60 var overvejende af IgG1-underklassen. Derfor 
kunne kryds-reaktivitet mellem human og bakteriel HSP60 ikke støttes som en 
patogen mekanisme for SpA sygdom. Desuden blev en svag korrelation mellem 
anti-humant HSP60 IgG3 og en af de mange sygdomsparametre demonstreret, 
hvilket genererede interesse for at gennemføre en opfølgende undersøgelse, hvor de 
samme patienter blev indkaldt igen. 
Det andet studie var et kohorte studie med 2 serumprøver fra samme patient med et 
4 års interval. Antistofferne målt i dette studie kunne da bestemmes over tid. Der er 
altså her tale om en undersøgelse af sammenhæng mellem antistof niveau og 
sygdomsforløb. Desværre blev kun 39 patienter (48%) af prøverne der var blevet 
analyseret i paper I indsamlet. Sandsynligvis på grund af det reducerede antal af 
patienter der deltog, kunnne der ikke påvises nogen sammenhæng mellem 
sygdomsparametre og antistoffer. Igen blev IgG subklasse specificitet for bakterielt 
og humant HSP60 præsenteret med en dominans af IgG3 til humant HSP60 og IgG1 
for bakterielt HSP60 hvormed hypotesen om krydsreaktivitet igen kunne afvises. 
I den tredje undersøgelse udforskes det faktum, at polymorfier i gener involveret i 
den medfødte immungenkendelse og cytokin-signalveje er blevet påvist blandt SpA 
patienter. Blandt disse gener er IL-1A, der betragtes som en pro-inflammatorisk 
cytokin produceret primært af makrofager på stedet for infektion. IL-1α syntetiseres 
som et 33 kDa forstadium peptid, som spaltes i mus af en calpain-lignende protease 
til et nukleært-associeret 16 kDa propiece og et udskilt 17 kDa modent IL-1α peptid. 
Da behovet for et funktionelt assay til at validere betydningen af SNP'er i IL-1α-
genet fremgår af litteraturen lavede vi et tidsforsøg, hvor humane makrofager beriget 
fra perifert blod blev stimuleret med et bakterielt endotoxin navngivet 
lipopolysaccharid (LPS) og farvet for propiece med et monoklonalt antistof (MAb 
1.3.2), der var genereret mod rekombinant precursor IL-1α. Endvidere ved at 
konjugere MAb1.3.2 til et fluorofor (FITC) lavede vi en flow cytometrisk analyse af 
IL-1α kinetikken hos humane monocytter. Med anvendelse af konfokal mikroskopi 
blev IL-1α propiece påvist at lokalisere til kernen allerede 2 timer efter LPS-
stimulering med øget intensitet på 12 og 20 timer efter LPS-stimulering. Desuden 
viste CD68 sig at være en gyldig markør for IL-1α producererende monocytter. 
Kinetikken for produktionen af IL-1α protein fulgte en mætningskurve, mens 
mRNA produktion var stærkest ved 4 timer.  
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Sammenfattende har resultaterne af denne afhandling vist 1) At antistoffer mod 
bakterielt og humant HSP60 ikke er en markør for SpA sygdomsaktivitet.  2) At IgG 
subklasse specificitet findes for human (IgG3) og bakteriel (IgG1) HSP60 og ikke 
understøtter krydsreaktivitet som en patogen udløser i SpA sygdom. 3) At IL-1α 
propiece lokalisere til kernen af humane makrofager og stiger eksponentielt over tid 
indtil 20 timer efter LPS-stimulering. Baseret på resultaterne af denne afhandling er 
den aldrende hypotese om molekylær mimicry, som en patogen udløser i SpA 
patogenese, usandsynlig. Dertil er der udviklet en platform tilgængelig for en klinisk 
undersøgelse, hvor donorer sekventeret for IL-1A gen variation valideres med 
målinger på IL-1α kinetik fra den udviklede metode i paper IV. Dette kan give vigtig 
viden om en potentiel funktionel rolle for IL-1A SNP’er ved SpA patogenesen. 
 VIII 
ABBREVIATIONS 
ADCC Antibody-Dependent Cell-
mediated Cytotoxicity 
ASAS Assessment of Spondylo-
Arthritis international Society 
ATP Adenosine TriPhosphate 
CD Cluster of Differentiation 
ESSG European Spondylarthropathy 
Study Group 
FSC Forward Scatter 
FITC Fluorescein IsoThioCyanate 
GWS Genome-Wide association 
Studies 
Hc Heavy chain 
HGNC HUGO Gene Nomenclature 
Committee 
HLA Human Leukocyte Antigen 
HSP Heat Shock Protein 
Ig Immunoglobulin 
IκB Inhibitor of NFκB 
IL InterLeukin 
ITAM Immunoreceptor Tyrosin-
based Activation Motif 
Lc Light chain 
MyD Myeloid Differentiation 
MHC Major Histocompatibility 
Complex 
MRI Magnetic Resonance Imaging  
NCBI National Center for 
Biotechnology Information 
NFκB Nuclear Factor kappa-light-
chain-enhancer of activated B cells 
NGS Next Gene Sequencing 
NLR NOD-Like Receptor 
PAMP Pathogen-Associated 
Molecular Patterns 
PBMC Peripheral Blood 
Mononuclear Cells 
PMT Photo Multiplier Tube 
RAcP Receptor Accessory Protein 
SpA SpondyloArthritis 
SNP Single Nucleotide Polymorphis 
SSC Side Scatter 
TCR T Cell Receptor 
TIR Toll-Interleukin Receptor 
TIRAP Toll-Interleukin 1 Receptor 
domain containing Adaptor Protein 
TLR Toll-Like Receptor 
TNF Tumor Necrosis Factor 
TABLE OF CONTENTS 
PREFACE…………………………………………………………………………...I 
ABSTRACT………………………………………………………………………...II 
DANSK RESUMÉ………………………………………………………………….V 
ABBREVIATIONS……………………………………………………………..VIII 
 
1. INTRODUCTION ................................................................................................ 1 
1.1 SPONDYLOARTHRITIS ........................................................................................ 1 
1.1.1. Cross-reactive antibodies to Hsp60.......................................................... 4 
1.1.2. IgG subclass characterization .................................................................. 6 
1.1.3. Interleukin-1 αlpha - gene, protein and biosynthesis ............................... 9 
1.1.4. Interleukin-1 and disease........................................................................ 12 
2. METHODOLOGICAL APPROACHES.......................................................... 14 
2.1 Indirect ELISA ............................................................................................ 14 
2.2 Isolation of monocytes/macrophages.......................................................... 16 
2.3 Flow cytometry............................................................................................ 17 
3. SUMMARIZING DISCUSSION....................................................................... 21 
3.1 Alarmins...................................................................................................... 23 
3.2 Cellular secretion pathways ....................................................................... 24 
3.3 Single nucleotide polymorphism in SpA ..................................................... 26 
3.4 Immune regulation ...................................................................................... 26 
3.5 Concluding remarks.................................................................................... 27 
4. AIMS OF THESIS .............................................................................................. 28 
6. REFERENCES.................................................................................................... 29 
 
SCIENTIFIC CONTRIBUTION 
Paper I - Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis, 
PloS One, Vol. 8, 2013. 
Paper II - IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity 
and progression over time in axial spondyloarthritis, Arthritis Research and Therapy, Vol. 15, 2013. 
Paper III - A role for anti-HSP60 antibodies in arthritis: a critical review, OA Arthritis, Vol. 1, 2013. 
Paper IV - Interleukin-1 alpha activation and localization in lipopolysaccharide-stimulated human 
monocytes and macrophages, Journal of Immunological Methods, Vol. 422, 2015. 
Not part of thesis - Neutrophil extracellular traps in ulcerative colitits: a proteome analysis of intestinal 
biopsies, Inflammatory Bowel Diseases, Vol.21, 2015. 
1. INTRODUCTION 
1.1 SPONDYLOARTHRITIS 
Spondyloarthritis (SpA) constitute a group of 5 immune-mediated inflammatory 
diseases: Ankylosing spondylitis (AS), Inflammatory bowel disease (IBD) arthritis, 
Reactive arthritis (ReA), Psoriatic arthritis (PsA) and undifferentiated 
spondyloarthritis (uSpA) (figure 1A). The name SpA comes from the two Latin 
words spondyl and arthropathy meaning vertebra and unspecific joint disease, 
respectively. Together the two words accentuate the most prominent clinical features 
shared among the various diseases affecting the spine (spondylitis), joints (arthritis), 
ligament and tendons (enthesitis) (figure 1B).  
 
 
Figure 1: A) A venn diagram illustrating the different disease groups of SpA. B) The shared symptoms of 
SpA (modified from Rosenbaum et al. 2012 [1]) C) The consequences of inflammation and ossification 
on the spinal vetrebraes in AS (modified from Maksymowych 2010 [2]). 
The most promintent pathological feature seen among SpA patients is inflammation. 
Under normal conditions this process is activated because foreign material is 
recognized by the immune system. This activates specific immune cells and triggers 
them to release toxic substances to combat the intruider. However, in SpA diseases 
this process is out of control as it for some unknown reason attacks the synovium of 
the sacroiliac- and spinal joints. The resulting inflammation is continuosly damaging 
the tissue, which is being counteracted by a reperative response that induce 
pathological bone calcification. This in turn causes the joints to loose their mobility. 
By means of radiography this is visualized by fusion of the vertebrae accompanied 
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with the development of so-called syndesmophytes (figure 1C). Initially, changes 
occur in the lumbar spine but will gradually spread upwards. Squaring of vertebral 
bodies is the first indication, which is followed by erosions and sclerosis of the 
anterior corners of the vertebral bodies and ossification of the annulus fibrosus 
(syndesmophyte formation). This pathology is characteristic for patients suffering 
from AS, which is considered to be the prototype of SpA. If not treated the 
calcification of spinal joints in these patients give rise to a characteristic curved 
posture also refered to as the “bamboo spine”.  
 
It is estimated that SpA as a group occurs in 0.5 to 1% of the population in Europe. 
Incidence rate of AS has been reported to be 7.3 per 100,000 adults in Norway and 
6.9 per 100,000 in Finland. It affects people of all age groups, but with a preference 
for men (2-3:1) at the age of 20-30 [3].  
 
Globally, 90% of AS patients are HLA-B27 positive. The HLA-B27 allele is located 
on chromosome 6 and codes for a major histocompatibility complex I (MHC-I) 
variant. MHC molecules are classed into MHC-I and MHC-II based on function and 
which cells they are present in. MHC-I molecules are constantly being processed 
and transported to the surface of all nucleated cells in the body. Here they present 
intracellular (cytosol) peptides (8-11 amino acids) to the adaptive immune system 
(figure 2A) through cytotoxic CD8+ T cells. If the CD8+ T cell recognizes the 
peptide as foreign (e.g. viral) the cell is killed. This creates a surveillance system in 
which the diversity of MHC class molecules and their peptide specificity are 
essential to manage the magnitude of different pathogens with preference for the 
human cell.  
 
Several hypotheses have been suggested explaining the association of SpA to HLA-
B27 [5]. One such hypothesis links HLA-B27 misfolding to the interleukin-23 (IL-
23) production through an unfolded protein response. As IL-23 is involved in the 
differentiation of CD4+ T cells into the proinflammatory Th17 lymphocytes this 
hypothesis has been supported by the high plasma IL-17 levels detected in patients 
with AS [6]. An older hypothesis, disussed in the next section, proposes that 
bacterial infection is the trigger of arthritis. A strong support for the involvement of 
bacterial infection in SpA is ReA (figure 1A), a non-purulent joint inflammation that 
usually follows a bacterial gastrointestinal or urogenital infection with a time 
interval of 1-3 weeks.  
 
The association of AS to HLA-B27 is strong. However, only 5% of HLA-B27 
positive individuals in the population develop SpA. This suggests the impact of 
other factors in the development of SpA and focus in the litterature has recently 
turned to the innate immune response to discover new contexts (figure 2B) [6]. 
 
Figure 2: A) The interaction between a CD8+ T cell and the major histocompatibility complex I (MHC-I) 
in which the HLA-B27 allele encodes the α1 domain involved in peptide recognition. B) The response of 
the human immune system can be divided into two parts described in the literature as innate and adaptive 
highlighting the difference in its development and ability to neutralize and remove pathogens from the 
human body. The initial mechanism of defence is performed by the innate immune response. It includes 
the skin and a variety of cells and soluble factors presented in the figure above (modified from Dranoff, 
2004). The recognition mechanisms of these cells is encoded in their genetic materiel and therefore 
termed innate. However, on the other hand, the adaptive immune response takes time to mature as it 
selectively improves its affinity for the pathogen and built up memory. It is presented by the following 
components: antibodies, B cells and T cell, which are divided into CD4+ and CD8+. Other cells with 
cytotoxic behaviour named γδ T cells and natural killer cells are believed to be involved with both innate 
and adaptive responses [7]. 
 
Treatment of patients is mainly carried out with an expensive anti-tumor necrosis 
factor (TNF) and nonsteroidal anti-inflammatory drug therapy, initiated to stop 
disease activity and development. After the acute phase of disease has ended 
patients are usually referred to a physiotherapist to begin training of joints to 
strengthen muscles and ligaments. Disease activity and progress is monitored by the 
use of blood tests, X-ray pictures, magnetic resonance imaging (MRI) scans and 
different indexes: Bath Ankylosing Spondylitis Functional, Disease and Metrology 
index (BASFI, BASDI and BASMI) [8]. Even though there is no cure the outcome 
of disease is very much dependent on early diagnosis for prevention of severe 
musculoskeletal symptoms. 
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For diagnosis, the rheumatologist combines the blodtest for HLA-B27 analysis with 
patient anamnesis, a physical examination of the back and hips and finally MR-
scans to detect bilateral sacroilitis and inflammatory back pain. Because the diverse 
clinical presentations seen among SpA patients may have a common background a 
number of different sets of criteria have been developed as to facilitate the diagnosis. 
These include: Amor, ESSG, ASAS and the (modified) New York criteria, which 
are reviewed elsewhere [3]. 
1.1.1. CROSS-REACTIVE ANTIBODIES TO HSP60 
In the 1980s a group of scientists made a rat model of juvenile arthritis (JRA) in 
which they identified a T cell specific for a sequence (epitope) within the 
Mycobacterium bovis bacillus Calmette-Guérin (BCG) antigen. Administration of 
this antigen to rats induced resistance to subsequent attempts to produce JRA and 
this molecule was therefore suggested to play a role in immune-regulation [9]. The 
antigen was later identified as the 65-kD mycobacterial heat-shock protein (HSP) or 
GroEL, which belongs to the HSP60 family of bacterial heat shock proteins [10]. 
Proteins within this family have shown to be highly conserved throughout evolution 
with close to 50% amino acid identity to its mammalian counterpart [11]. These 
findings led immunologists to believe that self-antigens, in this case HSP60, might 
be able to break immune tolerance as a result of “molecular mimicry” as outlined in 
figure 3 [12]. The history of this theory is reviewed in more detail in paper III [13]. 
Immune tolerance is a concept that explains the different mechanisms including 
central and peripheral tolerance that inactivates the immune response upon 
recognition of unharmful substances.  
 
The human HSP60 is an endogenous protein located within the mitochondria and 
today known to be involved in the transportation and refolding of proteins from the 
cytoplasm into the mitochondrial matrix. Because these proteins are involved in 
protein guidance, they have been given the name chaperones. Several HSP families 
exist and are designated after shared molecular weight (e.g. HSP10, HSP40, HSP70 
and HSP90). Their function and name come from experiments on polytene 
chromosomes from Drosophila Melanogaster in which specific areas of high RNA 
transcription (chromosome puffs) were linked to the expression of heat shock 
proteins after subjection of the tissue sample to a temperature shock (30 °C or more) 
[14-16]. 
 
Figure 3: An overview of the immunological processing of a bacterial infection with emphasis on the 
development of antibodies towards bacterial and human HSP60. Pathogen-associated molecular patterns 
(PAMPs), such as bacterial HSP60, is recognized by a pattern recognition receptors (PRR), believed to be 
toll-like receptor 4 (TLR4) [5, 6, 13, 17, 18], inducing engulfment of the bacteria by phagocytosis. A 
peptide (8-10 aa) from the bacterium is presented by the dendritic cell in a MHC II class molecule and 
recognized by the T cell receptor (TCR) on a helper T cell. A Conformational epitope on a bacterium are 
recognized by BCR on the B cell, which leads to phagocytosis of the bacterium. The charged helper T 
cell delivers secondary signals in the form of CD40L and cytokines stimulating the B cell to proliferate 
and develop into clones of antibody producing plasma cells specific for HSP60. Such antibodies have 
been suggested to be cross-reactive and involved in the inflammatory response seen in joints among SpA 
patients. 
The structural composition of the human HSP60 chaperones is best understood 
comparing it to “a barrel” or “isolation chamber” (see figure 1 in [13]). Generated 
by ATP and with affinity for hydrophobic patches, these chaperones take care of 
unfolded proteins needing the final touch after ribosome release. Since the human 
cell can be exposed to different stress situations (oxidative, metabolic & heat shock) 
as would be the case with inflammatory tissue the cell is engineered with an 
effective feedback system that responds to any increase in misfolded proteins by 
generating a response that upregulates the expression of HSPs. Human HSP60 has 
been shown to stimulate different effector components of the innate and adaptive 
immune system and considered to be very immunogenic with possible implications 
in cell damage signalling. In the literature such proteins are also named alarmins, the 
eqiuvelent to PAMPs (figure 3). 
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As a result, much research has focused on human HSPs and their immunogenic 
epitopes to evaluate their importance in different autoimmune diseases. Such studies 
include serological examination of antibody levels found towards human HSP60 
using the enzyme-linked immunosorbent assay (ELISA) [13]. Development and 
improvement of this technique have been a main research aim in the first 2 research 
papers of the thesis [8, 19]. The generation of antibodies to both bacterial and human 
HSP60 is presented in figure 3, which as results of their homology is believed to be 
cross-reacitve. Such antibodies have never been demonstrated to be of pathological 
importance in SpA, highlighting the need for more research. Paper I investigate an 
association between anti-HSP60 and disease while paper II investigate an 
association between anti-HSP60 and disease progression. 
1.1.2. IGG SUBCLASS CHARACTERIZATION 
The B cells are important effector cells of the humoral immune response that, upon 
maturation to plasma cells, produce and release a variety of antibodies 
(immunoglobulins, Igs) into the blood and infected tissues. Here the Igs function as 
a soluble defence-mechanism that target and neutralize intruders and their virulence 
factors. The naive B cells, which by definition have not recognized an antigen, are 
equipped with B cell receptors (BCR) anchored to the cell membrane through their 
C-terminal. The structure of a typical Ig can be seen in figure 4A, illustrating the 
BCR of a naive B cell.  
Figure 4: A) The BCR. B) Isotype switching of constant Hc genes. The IgM Hc can be seen as a single 
transcription unit of 4 exons. V: variable segment, D: diversity segment, J: joining segments, E: enhancer 
region,  : Promotor region. C) Biochemical structure of immunoglobulin G subclass 1 and 3 (IgG1 and 
IgG3). 
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The IgM molecule consists of 2 identical light chains (Lc) and 2 identical heavy 
chains (Hc), linked together by inter-chain disulfide bonds. The amino-terminal 
portion of the 2 chains is characterized by a highly variable amino-acid composition, 
which is involved in antigen binding and referred to as the complementary-
determining regions (CDR). The constant region of the heavy chains holds the 
molecule together and is involved in several effector functions such as complement 
binding and binding of high-affinity phagocyte Fc receptors. The hinge region 
between the Fc and constant region of Fab Hc gives the Ig its flexibility. Every Ig is 
accompanied with a co-receptor named cluster of differentiation (CD) 79, which can 
be seen next to the IgM molecule in figure 4A. CD79 is a membrane bound 
transmembrane heterodimer, which generates a signal into the B cell after antigen 
recognition by the BCR. This is coordinated by immunoreceptor tyrosine-based 
activated motifs (ITAMs), which is located at the intracellular tails of CD79. The 
forces that hold together the antigen:antibody complex are of noncovalent nature 
and involve forces such as hydrogen bonds, hydrophobic interactions and van der 
waals forces. An important aspect of this binding is the fact that Igs recognize the 
overall surface of the specific antigen (conformational epitope) and the contribution 
of the different forces depends on the particular Ig and antigen. Compared to other 
interactions seen among proteins the antigen binding possess many aromatic amino 
acids, which are important for pulling together the two surfaces that are 
complementary in shape. B cells mature in the bone marrow where the gene 
rearrangement and allelic exclusion of the H and L chains leads to the cell-surface 
expression of the BCR. After maturation, involving many different gene-regulatory 
proteins, the IgM+ B cells migrate through the bloodstream to secondary lymph 
nodes where they at first get localized in the follicles. If stimulated with antigen and 
activated by specific charged helper T cells (figure 3) the IgM+ B cells migrate to 
germinal centres. Within this microenvironment IgM+ B cells proliferate and 
undergo somatic hypermutation and isotype switching to create Ig diversity and 
increase antigen-binding specificity and avidity. This in turn leads to maturation of 
Ig producing plasma cells and memory B cells, which, upon a secondary infection 
involving the same antigen retaliates with immunity. Several of today’s vaccines are 
constructed to encourage this maturation of memory [20].  
 
The process of class switching involves changing of the constant region of the Ig 
Hcs (figure 4B). IgM is the first Ig to be secreted and expressed on the surface of 
naive B cells, which is a result of its position among the constant Hc gene segments. 
The recombination of Hc genes does not include the variable regions (CDR) and 
leaves the new isotype with no change in antigenic specificity. Thus, different 
daughter cells from the same activated B cell are able to produce Igs of different 
isotypes or subclasses (e.g. IgG1, IgG2, IgG3 & IgG4). This is an advantage because 
the different isotypes of Igs that differ in effector functions are preferred for 
different antigenic stimuli. The switch factor that determines the expression of these 
specific heavy chain genes comes from CXCR5+ charged T helper cells and involves 
specific receptor recognition and cytokines. Cytokines are small-secreted messenger 
peptides that are used for communication between cells and are essential for 
controlling and regulating many different cellular functions such as the germline 
promotors of Ig genes. CXCR5 is the receptor for CXCL13, the chemokine that 
attracts cells to B cell follicles. A recent study showed that B cells respond and 
switch to the production of Ig isotypes other than IgM more rapidly when CXCR5+ 
CD4+ T cells help them compared to naive CD4+ T cells [17]. Compared to Igs the T 
cells (CD8 and CD4) recognize only a linear sequence of a limited amount of amino 
acids from the original antigen. This reveals an important aspect of the association 
between B-& T cells, as they do not necessarily recognize the same epitope of the 
pathogen. Thus, if switched Igs (IgG) are found in serum with affinity for a given 
epitope these Igs reflect a previous interaction with an activated helper T cell but 
does not imply that the helper T cell itself would recognize exactly the same epitope. 
It might be a sequence hidden deep within the antigen. This interpretation leads to 
the possibility that preserved sequences within highly conserved proteins such as 
HSP60 could trigger a T cell generated autoimmune response.  
 
In humans 5 classes of Igs exist: IgM, IgA, IgD, IgE and IgG. Their genes are found 
in a large cluster located on chomosome 14. IgG is found to be the most abundant 
isotype in plasma and as a result of its small size it easily diffuse out of the blood 
and into tissues and extracellular fluids where it has its main function in neutralizing 
toxins, opsonizing pathogens and activating the complement system [21]. The IgGs 
can be further divided into 4 different subclasses designated IgG1, IgG2, IgG3 and 
IgG4. The subclasses differ in structure with special attention towards the hinge 
region and the position of disulfide bond linkage between Hc and Lc. In respect to 
the results presented in paper I and II only the biochemical properties of IgG1 and 
IgG3 is presented (figure 4C). The specific flexibility decreases in the order 
IgG3>IgG1>IgG4>IgG2 and is suggested to be a result of the higher activity of 
IgG3 and IgG1 in the ability to bind FcγR, when compared to the other subclasses 
[22]. Such binding trigger effector functions such as phagocytosis, endocytosis, 
release of inflammatory mediators and antibody-dependent cell mediated 
cytotoxicity (ADCC). IgG2 does not activate the complement system and has been 
shown to be the dominating subclass in anti-polysaccharide responses, which is 
regarded as a T cell independent response [23, 24]. IgG4 is still poorly understood 
but largely restricted to non-microbial antigens [25]. The IgG subclass distribution 
in an anti-bacterial response is heterogeneous, since bacteria contain many different 
antigenic components with variations in protein and carbohydrate structure. Serum 
concentrations of the human IgG subclasses show the following pattern: 
IgG1>IgG2>IgG3=IgG4. 
1.1.3. INTERLEUKIN-1 ΑLPHA - GENE, PROTEIN AND BIOSYNTHESIS 
“Interleukin” as a name is given to a group of secreted proteins also refered to as 
cytokines. They are produced by many types of cells but first seen expressed by 
leukocytes (leukin) that uses them for cell-to-cell communication (inter-). Today, 
close to 40 interleukins have been identified, which are named with “IL” followed 
by one or more numbers and letters (for example, IL1A) (HGNC).  
 
The IL1A gene is 11.48 Kb long and positioned on chromosome 2q14 (NCBI). It is 
part of the IL-1 gene cluster family neighbouring its homologue IL1B. Their given 
names reflect a history of a common ancestor (IL-1) and their trace record in the 
literature promotes that their products (IL-1α and IL-1β) are important inducers of 
inflammation [26]. 
 
Producers are primarily found among myeloid cells but keratinocytes and epithelial 
cells are also well-studied contributors of IL-1 production. Most importantly, 
however are the monocytes, macrophages and dendritic cells, which are known for 
their role as phagocytes and transmitters of immune responses, respectively. The 
precursor to macrophages is the monocyte, which is classified into the following 
subsets (human) based on the expression of surface markers CD14 and CD16: 
classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical 
monocytes (CD14+CD16++) [27]. These cells have been found to have different 
function in the blood circulation discussed elsewhere [28]. When the monocyte 
migrates from the blood to the tissue it differentiate into a macrophage, which have 
been divided into 2 different groups based upon the type of their activation.  
 
Differentiation of the classically activated macrophages requires LPS, IFN-γ, or 
TNF-α. The alternatively activated macrophages require IL-4 and/or IL-13 as stimuli 
[28]. The two subsets are also termed M1 and M2, respectively [29, 30]. M1 
machrophages is the source of IL-1 and the cell described in the following section 
(figure 5). In order for IL-1 to be produced by macrophages a stimulus of the pattern 
recognition receptor TLR4 is required. The downstream sequence of events is 
presented in figure 5A. The promotor sequence of IL1A contains bindings sites for a 
number of transcription factors including NFκB and AP-1 highlighting a very 
controlled but flexible regulation of gene expression. Once NFκB is translocated to 
the nucleus it binds the promotor via the general consensus sequence (ggg RNN 
YYC C, R=purine, Y=pyridine) transcribing the pro-inflammatory cytokines TNFα, 
pro-IL-1 and IL-6. 
 
 
Figure 5: Signal transduction and processing of IL-1α in a M1 macrophage. A) The binding of LPS to 
TLR4 on the surface of the macrophage forms a heterologous receptor complex. Anchored to the 
membrane CD14 and LPS binding protein delivers LPS to the TLR4-MD-2 receptor creating the TLR4 
dimer. The TLR4 dimer attracts the adaptor proteins TIRAP and MyD88. These adaptor proteins interact 
with TLR4 by TIR domains while MyD88 interact with partners through death domains. A box is 
highlighted to the right in which the signalling cascade is outlined. The final part of the transduction 
presents dissociation of IκB (orange) from NFκB allowing it to enter the nucleus where the transcription 
of proinflammatory cytokines takes place including pro-IL-1α mRNA. B) Pro-IL-1α processing. 1) Pro-
IL-1α is able to translocate to the nucleus without any modification. 2) Pro-IL-1α ︎ can be myristylated and 
translocate to the plasma membrane. 3) Pro-IL-1α can be cleaved by the membrane-associated enzyme 
calpain to an N-terminal propiece and mature IL-1α. Mature IL-1α is released and the N-terminal 
propiece translocates to the nucleus. C) In our study we generated a monoclonal antibody towards the 
precursor of IL-1α and conjugated the antibody to FITC presented in paper IV [26]. 
 
The translation of IL-1α makes a protein of 271 aa (Figur 5C), which along with IL-
1β contains no ER- or Golgi targeting sequence and hence secreted by an 
unconventional protein secretion pathway. Both proteins are processed into 
biological active parts by cleavage. IL-1α is cleaved in mice by calpain, a calcium-
dependent cysteine protease resulting in a nuclear-associated 112 aa propiece and a 
159 aa mature and secreted version (figure 5B). In comparison with IL-1β, the 
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cellular mechanism of IL-1α secretion still miss consensus among researchers. 
Recent discoveries by two independent groups Fettelschoss et al. (2011) and Groß et 
al. (2012), however, have made important progress [31, 32]. Both groups agree that 
the secretion of IL-1β depends on proteolytic cleavage by caspase-1, which is 
activated by a pathogen-sensing multiprotein complex referred to as the 
inflammasome (a very detailed visualisation of these steps can be found in the 
review of Dinarello et al. (2009), figure 1) [33]. However, more difficult is it to 
agree on the dependency of the inflammasome in IL-1α secretion, which has 
resulted in a follow-up comment on the two independent research results by Yazdi et 
al. (2012) [34]. In the paper of Fettelschoss et al. (2011) they find evidence to 
support that IL-1β acts as a chaperone for IL-1α secretion. Furthermore, they discuss 
that TLR activation is sufficient for the production of surface IL-1α, whereas the 
secreted version needs additional activation of the inflammasome, most notably 
NLR family, Pyrin domain-containing 3 (NLRP3). In order to activate the complex 
the researchers made use of uric acid crystal and nigericin. Working with the same 
research question, the group of Groß et al. presented an inflammasome-independent 
secretion of IL-1α via crystalline activators. These findings have demonstrated a 
need for fourther research to identify the specific circumstances by which IL-1α is 
secreted and cleaved. 
 
 
Figure 6: Signal- or no signal transduction for IL-1. 1: IL-1α binds to IL-1R1 recruiting IL-1RAcP. The 
binding forms a heterodimeric receptor and triggers the event outlined in figure 5A. 2: IL-1R2 is a decoy 
receptor, which can also bind IL-1α but does not recruit the interleukin-1 receptor accessory protein (IL-
1RAcP). Hence, no signal is transmitted to the inside of the cell. 3: IL-1Ra is an IL-1 receptor antagonist 
that upon binding to IL-1R1 prevents the recruitment of IL-1RAcP [33]. 
 
The reason why it could come as a surprise that the related cytokines, IL-1α and IL-
1β, have different biological functions is demonstrated in their affinity for the same 
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receptor IL-1R (Figure 6,1). Furthermore, the proteins are related by gene 
organization, sequence similarity and gene organization. In order to control the 
system several mechanisms have been found in which IL-1 signaling is blocked as 
outlined in Figure 6,2. This makes good sense as the multiple roles for IL-1 present 
itself in disease-related biological processes including inflammation, wound healing, 
metabolism, immunomodulation and the endocrine system [35]. Therefore, a defect 
in the system would quickly manifest itself in clinical symptoms, such as fever and 
rash. 
1.1.4. INTERLEUKIN-1 AND DISEASE 
The understanding of the genetic defect in IL-1-associated diseases improved with 
the finding of a gain of function mutation (mutation that confers new or enhanced 
activity on a protein) in the gene that encodes the inflammasome (CIAS1) [34, 36, 
37]. Diseases include familial cold autoinflammatory syndrome, Muckle-Wells 
syndrome, gout, type II diabetes, inflammatory- and autoimmune diseases. Many of 
them have been treated with the IL-1 receptor antagonist anakinra (figure 6,3) with a 
positive clinical outcome but most notably rheumatoid arthritis (Ra). Ra is 
considered an autoimmune disease with uncontrolled inflammation in synovial 
membranes of the small joints of the hands and feet. Furthermore, they have an 
accumulation of mononuclear phagocytic cells in the lining layer, which presents the 
close contact between producer of IL-1 and inflammed tissue [38]. Arthritis as a 
medical term, however, is differentiated into a large number of diseases with 
differential diagnostic issues in the clinic and hence brought the interest of IL-1 
genetics into many athrogenic diseases. Sequentially, the search for a genetic defect 
has been aligned with next generation sequencing technology producing a number of 
genome-wide association studies (GWS) that links SNP’s to the development of 
disease. Such studies have recently (<10 years) been published in which the diseases 
of SpA have been linked to SNP’s in IL-1α.  
 
These findings present investigations in which a statistical approach is used to 
compare sequencing results of genetic material from diseased and healthy 
volunteers. Maksymowych et al. (2006) finds rs3783526 (IL1A) to be associated 
with SpA [39]. Sims et al. (2007) finds strong association with three single 
nucleotide polymorphisms (SNPs) in the IL1A gene (rs2856836, rs17561, 
rs1894399) [40]. In the Monnet et al. study (2012) the SNP rs2856836 and 
rs1894399 in IL1A was significantly associated with spondyloarthritis and AS, 
respectively [41]. Finally, The Lea W-I et al. (2012) study finds that the OR of the 2 
allele of IL-1A + 889 (rs1800587) was found to be significantly increased in 
Europeans with AS [42]. 
 
Together with IL-33 the IL-1α protein is described in the litterature as a dual 
function cytokine explained by the biological activity of both cleavage products. The 
role of nuclear association is believed to be part of a mechanism to alarm the 
immune system upon cellular damage. The same has been applied for human HSP60 
as autoantibodies are found in healthy individuals and increased in a number of 
diseases with an inflammatory pathogenesis. Hence, as for IL-1β, many years of 
research have studied the biological processeing of inflammatory cytokines as they 
present potential targets for the development of immune-modulators such as the IL-1 
receptor antagonist (IL-1Ra) analog Anakinra (figure 6,3).  
 
Results from studies investigating the effect of Anakinra as therapeutic for treatment 
of SpA have not been encouraging and with different outcome. In a study by Tan et 
al. a 61% reduction in spinal and/or sacroiliac joint MRI inflammation was observed 
[43]. Hence, the conclusions so far, based on open studies, are that Anakinra is 
mildly efficacious. However, as 20-25% of patients do not respond to Anti-TNFα 
treatment alternative options are needed. Such alternatives could be blocking for 
inflammatory cytokines such as IL-6 (tocilizumab) or IL-17 (Secukinumab). In 
comparison to IL-1β, IL-1α have been found to function both as a secreted and as a 
membrane-bound cytokine and hence, can trigger and sustain inflammation locally, 
especially in tissue of dying and necrotic cells. This is maintained by the induction 
of several substances such as phospholipase A2, cyclooxygenase-2, and nitric oxide 
causing pyrexia, hypotension, and induction of acute-phase reactants. The different 
mechanism of action between the two cytokines may hide alternative treatment 
strategies. Therefore, further research is needed to elucidate the mechanisms of 
production for IL-1α among inflammatory cells and if such measurements could 
elucidate a role for IL-1α in SpA. A first mover would be to create an assay usable 
for an investigation of a possible functional link betwenn IL-1α SNP’s and induction 
of IL-1α in humans. The association of IL-1α propiece with the nucleus have created 
a window for a new indirect aproach to determine the kinetics of IL-1α in human 
monocytes outlined in paper IV[26].  
2. METHODOLOGICAL APPROACHES 
The 3 main methods used in this thesis will be described in the following sections. 
2.1 INDIRECT ELISA 
Enzyme-Linked Immunosorbent Assay (ELISA) is the preferred solid-phase assay 
for clinical serology studies with a large sample size. The assay is carried out with a 
few steps (figure 7) and positivity can be visualized from the development of colour 
in a 96-microwell plate, which is measured with spectophotometry. 
 
 
Figure 7: Antigen is targeted with antibodies from the serum before being detected through an enzyme-
linked antibody that turns a substrate into a readable coulor, which is converted to optical density units. 
 
To determine the presence of specific antibodies, such as the subclasses of IgG, the 
preferred strategy is referred to as indirect ELISA (figure 7). The assay can measure 
antibodies produced in vivo in humans and therefore reflects the outcome of a 
natural, human immune response against a given antigen. This strategy was adopted 
to measure antibodies in serum from the SpA patients. The time-consuming part is 
the need of optimization between different patient groups. Therefore it is important 
to understand how the different components of the assay reflect the final optical 
density (OD) reading [44]. One of several considerations would be the 
immobilization of antigen, which bind to the UV treated surface of polystyrene. A 
high concentration of antigen may not allow antibody to bind through steric 
inhibition. The easiest way to access this is by making a so-called chessboard 
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titration (CBT) where serum that contains antibodies against the antigen is diluted to 
make titration-curves for different antigen concentrations [44]. This enables the 
practician to choose the best concentration because a plateau from the OD readings 
would indicate when antigen is in excess. The best concentration of antigen is where 
the OD level decreases as soon as the serum is diluted creating the most sensitive 
assay. The same applies when the concentration of enzyme-conjugated antibody is 
evaluated (figure 8).  
 
Because the primary antibody (serum sample) would be measured incorrectly if 
antigen or enzyme-conjugated antibody were in deficit we choose to add a high 
dilution of antigen (4 µg/ml), and then decided the dilution for the enzyme-
conjugated antibody. In figure 8 an example of titration curves is shown 
(unpublished). The black and blue dotted gray lines have reached a plateau at low 
serum dilutions (1/20, 1/40 and 1/80) indicating that a lower concentration of 
enzyme-conjugated antibody is needed. A dilution of 1/20000 has an optimal 
titration as it declines as soon as the serum is diluted and thereby giving the assay 
high sensitivity.  
 
Figure 8: Titration curves used to choose the optimal concentration of enzyme-conjugated antibody (see 
text). A serial double dilution (1/20 – 1/640) of serum from patient 81 (Study I), who is seropositive for 
C.jejuni HSP60, was treated with different concentrations of enzyme-conjugated sheep-anti-human IgG1 
(1/2500 – 1/80000). The plate was coated with 4 µg/mL Campylobacter jejuni HSP60. The X-axis is 
log10 transformed. 
The CBT measurements can be evaluated using serum from a patient from the 
cohort with the highest OD reading. This ensures that the chosen concentration of 
enzyme-conjugated antibodies maintains the OD-readings for the entire patient 
material below the limit of detection set by the spectrophotometer. Because the 
measurements have to be quantified, the chosen curve should give an OD level that 
corresponds to a dynamic area of the standard curve (i.e. before it reaches a plateau). 
Usually an OD around 1,5-1,7 is preferred.  
 
To quantify the measurements of IgG content (ng/mL) in serum the OD of the 
sample can be interpolated into a standard curve (an example of this is present in 
paper II [19]), which is typically a serial dilution of the target. In this case Nunc™ 
Maxisorp plates were coated with dilution series of native IgG1, IgG2, IgG3 and 
IgG4 from human myeloma plasma in CCB buffer (100 mM NaCO3, pH 9,6). 
 
Every plate is made with two blanks (only buffer), representing unspecific binding. 
The mean value of the blanks plus two times the standard deviation (SD) was 
subtracted from every patient sample measurement, which represents limit of 
detection. Patient and control samples were placed alternatively together in the 
setup, so in every plate both patients and controls were analysed. This prevents a 
bias between the patient-group and the control group caused by plate variation. Bias 
due to inter-assay variation, which is normally 5-15%, was reduced by adding a 
control sample on each plate, hereby quantifying the variation between different 
plates from different days.  
2.2 ISOLATION OF MONOCYTES/MACROPHAGES  
The ability to isolate the cell of interest is often the first step to overcome when 
human blood is being studied and has been a major part of the scientific process in 
the last paper of this thesis. The isolation of mononuclear cells based on the 
principle of centrifugation dates back to 1968 [45]. The discovery was made by Dr. 
Arne Bøyum and the commerzialisation of the principle have been named 
lymphoprep™. The medium has a density of 1.077 g/mL, which upon centrifugation 
seperates monocytes and lymphocytes (peripheral blood mononuclear cells 
(PBMCs), < 1.077 g/mL) from other components of the blood such as 
polymorphonuclear cells and thrombocytes (figure 9B). In order to get the best 
separation of cells the preperation of the two layers (i.e. blood and lymphoprep™) 
must be done with caution so the layers do not mix before centrifugation (figure 
9A). Hereafter cells can be removed from the interface, washed and transfered to 
medium for culturing. 
 
Figure 9: A) Preperation of blood with lymphoprep™ before centrifugation B) Illustration of the impact 
of centrifugation on the different components of blood C) Microscopy image of machropages with a red 
nuclear stain and a green stain for CD68 (modified from [26]). Microscopy was performed on a SP5 con-
focal microscope (Leica) with a CX PL APO 100x/1.47 OIL CORR TIRF objective. 
 
Monocytes adhere to plastic, which is fueled by the prescence of serum in the 
medium. The prescence of extracellular proteins (such as fibronectin) in serum 
creates a surface that attracts specific surface proteins of the monocytes promoting 
attachment and simulating the in vivo migration of monocytes into the tissue 
initiating machrophage differentiation [46]. This cellular trait can be used for 
immunostaining (figure 9C) to identify markers valuable for cell identification or 
viability. Such a method was used for the identification of intracellular localization 
of IL-1α propiece in human macrophages in paper IV [26]. 
2.3 FLOW CYTOMETRY 
The explanation of this method is in the name as cells (cyto) in motion (flow) is 
being measured (metry). The technology is best understood with a view of the flow 
cell, in which the sample is injected at the start of a run (figure 10). An important 
part of a succesful read of a complex cell sample is the ability of the flow cell to 
make cells pass the laser/s one by one. This is accomplished from hydrodynamic 
focusing, a technique that alters the velocity of the central fluid of the sample by 
passing faster moving sheath fluid on each side of the central core (figure 10B). 
Leaving the flow cell stained cells are then illuminated with a laser that scatter upon 
impact. The scattering is dected at two angles that measure cell size (<10 degrees) 
and granularity (90 degree) also refered to as forward (FSC) and side scatter (SSC) 
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(figure 10C). Furthermore, fluorochromes on cells are detected as they get excited 
from the specific wavelenght of the laser and emit light at another wavelength. 
Emitted SSC and fluorescence signals are diverted by mirrors and optical filters to 
the photomultiplier tubes (PMTs) and a photodiode collects the FSC signal. By this, 
optical signals are converted into electronical signals (voltage) and finally into a 
digital number by the analog-to-digital converter (ADC) that can be visualized and 
analyzed with computer software. With the ability to detect up to 20.000 cells/sec 
and the inclusion of multiple lasers in newer flow cytometers and an even more so 
incomprehensible amount of different fluorochromes has made flow cytometry a 
favourite method of choice for cellular research [47]. 
 
 
Figur 10: The flow cell. A) A sample, such as lymphoprep™ isolated PBMC’s, are cultured, stained and 
kept in suspension. B) Hydrodynamic focusing is a technique that creates the single flow of cells 
important for accurate measurements (see text). C) Cells scatter light when they pass through lasers 
beams. The level of light scattering in straight (forward) direction is proportionate to cell size. Cells also 
include granules, compartmented nuclei and other organelles. This leads to side scattering of light. Side 
scattering depends on cell structure (e.g. granularity). A diagram of excitation and emission spectrums of 
common fluorochromes is presented created from BD fluorescence spectrum viewer. This is a nice tool to 
validate the chooise of fluorochromes before staining. Sometimes when polychromatic flow cytometry is 
needed potentiel overlap of spectrums between fluorochromes requires compensation to remove false 
positives [48]. 
 
A typically cytogram of common blood cells is presented in figure 11A. The higher 
up the y-axis the more side scatter and hence granularity of the cell. The same 
applies to cell size forward scatter located out the x-axis. As lymphoprep™ is used 
for isolation only lymphocytes and monocytes are expected to be present from a 
sample. This is visualized from the cytogram in figure 11B where 
polymorphonuclear cells with high granularity are excluded. If enough cells are 
collected it is possible to locate the different populations, which in data software, 
such as FlowJo™, can be gated out of the total cell sample for further analysis of 
specific cell markers (figure 11B). For monocytes this could include a panel of 
CD14, CD16, CD68 or CD163 [30]. Even though the flow cell is equipped with the 
laws of physics in terms of hydrodynamic focusing cells that stick together could stil 
be an issue of concern. Therefore it is recommended to make a FSC-W vs. FSC-A 
plot to remove aggregates to improve the quality of analysis. The principle is 
explained and visualized in figure 11C. 
 
Figure 11: A) The placement of cells from blood in a forward (FSC-A) and side scatter (SSC-A) diagram 
also refered to as a cytogram B) Gating (G1, G2 and G3) for population of cells using FlowJo™. C) 
Doublets is removed by a FSC-W vs. FSC-A plot before data analysis (unpublished data). A pulse is 
generated when cells enter the laser beam and the width of this pulse presents the time the cell is in the 
beam and therefore an indicator of cell size. Resolving singlet cells from aggregates is based on the fact 
that aggregates are larger than single cells and will have a greater pulse width signal than singlet cells. 
These aggregates can be seen to the right of singlet cells in a FSC-W vs. FSC-A plot. 
 
The remarkably speed of flow cytometry is overt. However, the information from a 
flow cytrometric analysis comes with limitations. This can be explained from the 
principle of fixation, part of the staining protocol. The most commonly fixative for 
cells is formaldehyde. The effectcs of formaldehyde is produced from its ability to 
react with side chains of proteins to form reactive hydroxyl-methyl groups. These 
reactive complexes may combine with each other forming methylene bridges or 
cross-links, preserving or fixing the antigenic structures in the cell important for 
staining purposes. However, as cells are fixed the window for analysis only concerns 
the cell state at the fixation point. Therefore, a peek into the behaviour of a specific 
subset of cells (e.g. activated T cells) in time and space is limited. Today, the ability 
Neutrophils
Monocytes
Lymphocytes
Debris
Single Cells
A B C C
G1
G2
G3
to track the polarization of the immune response is based on the identified cells and 
cytokines produced from the isolated biological material under investigation. 
However, when a sample derives from tissue with chronic inflammation some of the 
identified cells may be present with a phenotype that fluctuates at levels unsuitable 
for fixing chacterisation. In other words, the in vivo polarization of a single cell in 
that network would be destroyed and so would the analytical significanse. 
Approaches to circumvent this issue is the development of single cell technologies 
reviewed elsewhere [49]. 
3. SUMMARIZING DISCUSSION 
The intention of this thesis was to look for a triggering agent that would explain both 
the bacterial infections and specific genes involved in the predisposition to SpA. 
Therefore, bacterial HSP60 and the genes HLA-B27 and IL-1A was investigated with 
emphasis on immunological dysfunction. Antibodies to bacterial HSP60 and human 
HSP60 were compared and an indirect method for IL-1α quantification in 
monocytes was conducted [8, 19, 26]. Hence, this work include information on both 
adaptive (cross-reactive antibodies) and innate immune responses (macrophages) 
belived to be of importance in SpA pathogenesis. Based on this thesis the hypothesis 
of molecular mimicry could not be supported and groundwork for a functional 
analysis of SNP’s in IL-1A was demonstrated. However, the missing link that 
explains the association between genes, immune regulation and the environment 
responsible for SpA pathogenesis is a massive challenge (figure 12). 
 
  
Figur 12: A visualization of the complex research path of SpA pathogenesis. 
 
The products of the two genes highligted in this thesis respresent different molecular 
functions, however the potentiel consequences of their dysfunction is obvious. HLA-
B27 molecules present peptides to CD8+ T cell and if peptides are presented 
abnormally it may trigger an inflammatory response. IL-1α is a proinflammatory 
cytokine that with a defect in it’s thightly controlled expression system, could cause 
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damage to sorrounding tissue (1.1.3). How these components including Anti-HSP60, 
HLA-B27 and il-1α could make up a combined pathology for SpA is difficult to 
imagine. It would suggest that a defect HLA-B27 molecule (MHCI) breaks it's own 
role for cell specificity and presents a peptide of HSP60 to an autoimmune prone 
CD4+ T cell that upon recognition travels to the germinal center and activates a B 
cell with affinity for HSP60 to make antibodies. Aligned with this the CD4+ T cell 
would also produce INF-γ that activates tissue macrophages to produce IL-1α. 
Supporting the ability for HLA-B27 to present larger peptides mimicking a MHCII 
molecule comes from a study by Urban et al., (1999). With the use of a monoclonal 
antibody (MARB4) towards a subset of HLA-B27 molecules they investigated the 
length of bound peptides by mass spectrometry and Edman sequencing. Here they 
actually observed the binding of larger peptides (>9 aa) by HLA-B27 subsets. 
However, further analysis in a transfected cell line with a defective TAP1/TAP2 
complex (protein transportation) suggests that MARB4 recognize peptides destined 
for further trimming as HLA-B27 detection was abolished [50]. 
The biological properties of the HLA-B27 molecule has been investigated 
exstencively with special attention to antigen presentation and the so-called 
”arthriogenic” peptide among the B27 allele family [51]. However, the development 
of a spontanous inflammatory phenotype in b27/human β2-microglobulin mice 
knocked down for CD8+ T cells have generated noise on their importance in SpA 
pathogenesis [52]. This said, newer studies have shown both genetic assocciation of 
SNPs in CD8+ T cell genes (RUNX3) and their precense in high number in synovial 
fluid of PsA patients suggest that mouse as an inflammatory model may be 
inapplicable [53-55]. Three decades have passed and the mystery of HLA-B27 still 
exists. However, improvements in technologies that create and combine both 
genome and proteome measurements on biological systems including next 
generation sequencing (NGS), polychromatic flow cytometry and mass spectrometry 
creates more analytical power, which looks very promising for the future [49]. 
3.1 ALARMINS 
The term alarmins was introduced at a meeting on danger signals in Milano 2006 by 
Joost Oppenheim [56]. Both HSPs and IL-1α are found on the unfinished list of 
alarmins and their primary roles in mammalian physiology as chaperones and 
pyrogen have suggested that evolutionary forces can reuse old proteins for new 
purposes. Hence, exploring the immune system from an evolutionary perspective 
can be very useful for it’s understanding. Many processes such as the maturation of 
lymphocytes and the modification of antigenic specificity among receptors of the 
adaptive immmune reponse arise from the principles of evolution stating that a 
selection for best fitness improve the gene pool. The need for this process is obvious 
as the change of genes among bacteria and viruses apply to the same principle. This 
evolutionary arms race between the mammalian cell and microbes have had and still 
have a huge impact on the cellular processes that are being explored by invading 
microbes. In this context one would argue that the development of subclasses for 
IgG have evolved to combat increased diversity of bacterial antigens. More so, to 
indirectly protect the mechanisms of tolerance and reducing the negative effects of 
cross-reaction. Applying the same theoretical approach to IL-1α is discussed in the 
next section.  
3.2 CELLULAR SECRETION PATHWAYS 
Looking at diversity in cellular activites from an evolutionary perspective also 
applies to the lack of knowledge on secretion of proteins not destined for the 
classical pathway. Such proteins including IL-1α lack a hydrophobic N-terminal 
sequence that allows entry to the ER-golgi pathway. The quistion arises ”why do 
mammalian cells actually need additional secretory mechanisms besides the 
classical pathway?” [57]. Some of these proteins include angiogenic growth factors, 
inflammatory cytokines (such as IL-1α) and components of the extracellular matrix, 
which regulate cell differentiation, proliferation and apoptosis. All these functions 
could be considered to have important roles for cellular responses to environmental 
change. As the primary role for IL-1α in monocytes is to activate an immunological 
response upon recognition of PAMPs, it would seem very likely that such a response 
would be selected for by its speed and their biogenesis would therefore not be suited 
for ER and golgi trimming (figure 15). That said, not much research exists on the 
kinetics of protein secretion from nonclassical pathways and to what extend they 
exceed the secretion kinetics of the classical pathway. A study by Hirschberg et al. 
1999 made measurements on protein movement in a live COS cell (fibroblast cell 
line from monkey kidney tissue) by fluorescence recovery after photobleaching 
(FRAP) [58]. The method makes use of a fusion protein tagged with GFP. The 
investigated protein was a mutant of the stomatitis virus glycoprotein, which can be 
accumulated in the ER at 40 ºC and released to the secretory pathway be shifting the 
temperature to 32 ºC. During the FRAP approach, a small area of the fluorescent 
sample in the region of interest is permanently photobleached by intense laser 
illumination and the cells monitored over a period of time. If the protein in question 
is immobile then the bleached area will remain dark as there is no protein movement 
to replenish the signal. If however the protein (or a fraction thereof) is mobile, then 
unbleached mobile fluorophores from outside the bleached region will move/diffuse 
into the area and bleached proteins may in turn move out of the dark area. The rate 
of this recovery is a function of the protein, enabling the kinetics of movement to be 
calculated. 
Figure 14: The difference between processing steps involved in the classical and nonclassical pathways 
indicate the need for more modification of proteins destined for the ER and golgi (G). Some known 
proteins not destined for the classical secretion pathway has been presented to the left. K: represents a rate 
by which either stimuli (STIM) or molecules is transferred from one compartment to another. PM: plasma 
membrane. 
From this study mean rate constants for ER-golgi transport was 2.8%/min whereas 
golgi-plasma membrane transport was 3%/min wheras recidense times in both the 
ER and golgi was estimated to 40 minutes. The percentages represents the fraction 
of molecules transfered pr. unit time, specifying the fraction of the content in one 
compartment (i.e. ER) that flow to a downstream compartment (i.e. golgi). These 
results, allthough not from a human cell, indicate that time needed in the ER and 
golgi apparatus exceed what would be possible to proceed prior to the response 
measured for IL-1α. Furthermore, these protected secretion mechanisms opens a 
window for important targets that could be of interest to biomedical research. It also 
highligts the fact that other parts than transcription and translation may be affected 
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by mutations in IL-1A. Such parts could include secretion pathway/s of IL-1α in 
which the engagement between mature IL-1α and transporter proteins is affected.  
3.3 SINGLE NUCLEOTIDE POLYMORPHISM IN SPA 
In line with the affordability of next-generation sequencing (NGS) methods studies 
that explore associations between gene variants and specific disease traits have 
exploded. These so-called genome-wide association studies have generated a lot of 
data on the genetic complexity in SpA disease. In one such study endoplasmic 
reticulum aminopeptidase 1 (ERAP1) have been shown to be associtated with AS in 
HLA-B27 positive patients only [54]. As ERAP1 is involved in the trimming of 
peptides for the groove of the HLA-B27 molecule it suggests a gene-gene 
interaction in which the stability of peptide presentation could be affected by SNP’s 
in ERAP1. However, as for IL-1A, it remains to be proven if such small risk 
fractions (compared to that of HLA-B27) can be associated with a functional 
phenotype in disease. However, from an imunological point of view SNP’s in IL-1A, 
could have an effect on the regulation of both release and shot-down of secreted IL-
1α with dramatic consequences for the sorrounding tissue. 
3.4 IMMUNE REGULATION 
Chronic inflammation is the pathological description that drives the symptoms 
observed among SpA patients. Even the triggering diseases such as psoriasis and 
inflammatory bowel disease (IBD) that lead to SpA has inflammation as the first 
symptomatic clinical criteria. Therefore, whatever may be the trigger, it intervienes 
with the tolerance or balance of the inflammatory response. Hence, understanding 
the regulation of inflammation is crucial. Both human HSP60 and IL-1α propiece 
are found within the cell at normal homeostasis. Human HSP60 within the 
mitochondria and IL-1α propiece in the nucleus. As they appear in the extracellular 
environment both of them give rise to autoantibodies, which have been observed to 
be elevated in a number of inflammatory diseases [13, 59]. However, none of these 
findings have given any diagnostic advantages to SpA patients and a role as 
unharmful alarmins of cell damage seems most likely [56]. The generation of anti-
HSP60 and anti-IL-1α T and B cell epitopes in healty subjects prior to the 
generation of autoantibodies quistions how the immune system maintain the 
peripheral tolerance (figure 3). It is argued here to be a combined inhibitory action 
of Treg cells and the FcγRIIB, which is expressed on both monocytes and 
macrophages. Treg cells regulate immune responses and are regarded as the primary 
mediators of peripheral tolerance. Mechanisms of action include inhibitory 
cytokines, suppresion by cytolysis, suppresion by metabolic disruption and finally 
suppresion by modulation of dendritic-cell maturation or function reviewed 
elsewhere [60]. FcγRIIB, not to be confused with CD16 (FcγRIIIA and FcγRIIIB), 
has inhibitory function acting through its immunoreceptor tyrosine-based inhibitory 
motif (ITIM) (figure 14). These mechanisms hide targets for theraputic interventions 
and hence the ability to control inflammation and autoimmunity. The IgG1 and IgG3 
subclasses that have been shown to target human HSP60 in this thesis is the 
preffered antibodies recognized by FcγRIIB [61-62]. Questions arise, however, if 
these mechanisms have tresholds and what these are. Such threshold values could 
represent a saturation point for the regulatory component and clear the path for 
autoimmunity.  
 
 
Figur 14: A view of the different Fc receptors expressed on monocytes and macrophages (modified 
from [61]). There are four activating FcγRs expressed on monocytes/macrophages: the high-affinity 
receptors FcγRI, which can bind monomeric IgG, and two low-affinity receptors (FcγRIIA, FcγRIIIA and 
FcγRIIIB), which are restricted to bind immune-complexed IgG. FcγRIIB is the only inhibitory FcγR. It 
is a low affinity receptor that binds immune-complexed IgG that contains an immunoreceptor tyrosine-
based inhibitory motif (ITIM) in its cytoplasmic domain. The cross-linking of FcγRIIB by immune 
complexes results in ITIM phosphorylation and inhibition of the activating signal [61-62]. 
3.5 CONCLUDING REMARKS 
The ability to diagnose SpA as early as possible is very important for the prognosis. 
The earlier a diagnosis is given to the patient the earlier treatment can begin and 
hence reduce the amount of damage inflammation can cause to joints and ligaments. 
This is the primary goal and challenge that rheumatologists face with SpA. 
Historically, this challenge has produced many modifications of the criterias used 
for diagnosing SpA dating back to the Rome criteria in 1961. The hallmark for the 
diagnosis of axial involvement in SpA is radiography of the sacroiliac joint. 
However, this method has been shown to be insensitive to early bone and joint 
damage. With the introduction of magnetic resonance imaging (MRI) the ability to 
visualize early structural changes have increased diagnostic sensitivity and improved 
the usuabilty of anti-TNF treatment. Such measurements were included in paper II 
in order to track disease activity of the patients thereby also improving the 
robustness of the clinical characteristics [8]. However, these procedures (MRI scans 
and anti-TNF treatment) require resources and come with great costs to society. In 
this context a disease marker traceable from urin, faeces or blood able to 
differentiate the subgroups of SpA would be diserable and give a better and targeted 
treatment.  
 
In this thesis, a disease marker has been searched for among subclass antibodies in 
serum to bacterial and human HSP60. The marker would exist because of molecular 
mimicry stating that similarity in the proteins would give rise to an inapropiate 
immune response to human HSP60 and hence explain the chronic inflammation in 
the joints of SpA patients (1.1.1). Unfortunatly, these levels of antibodies, in 
combination with clinical parameters, did not have the capacity to differentiate 
between SpA patients and healthy donors. However, knowledge from the studies in 
this thesis still contributes to the analysis of cross-reactive antibodies in SpA 
pathology. Because of the subclass differentiation that exist between bacterial and 
human HSP60 the hypothesis of molecular mimicry cannot be supported. 
 
A marker does not need to be expressed; it could just as well be hidden in the 
genetic setup of patients, such as HLA-B27, which is found among 90% of AS 
patients. With the development of NGS more than 10 genes with SNP’s have proven 
to be significantly associated with SpA including IL-1A from GWS. Some of these 
genes concern inflammation (LTBR-TNFRS1A, IL23R and IL-1A) and apoptosis 
(CARD9) while others concern peptide trimming (ERAP1) and protein transport 
(KIF21B). Solving the mystery of SpA pathogenesis in the future will most likely 
come from research that quistions how this “trace puzzle” fit together. 
 
4. AIMS OF THESIS 
At the opening of the Danish parliament 7.9.2014 the former Danish Prime Minister 
Helle Thorning-Schmidt gave a speech from which the following section has been 
extracted and translated into English: 
 
I received an email from a man of 49 years who suffer from arthritis of the spine. It is a terrible and 
debilitating disease. Medications can relieve some of the pain. It costs 30,000 dollars a year, and as he 
writes, he will not have to pay, "because I'm so lucky to be a Danish citizen." He also writes that it took 
too long before he got his diagnosis. So long, that the disease spread so much that even the best medicine 
cannot fix what has already been destroyed. And therefore the 49-year-old man wrote in his email to me: 
"It is extremely important to diagnose much earlier than in my case." 
 
The diagnosis of this particular disease is very likely to be AS and the patient 
highlights the challenges that rheumatologists are dealing with in the clinic. 
Furthermore, it also implies why it is important that more research is conducted on 
the pathogenesis of SpA. That being said the overall objective of this thesis is to 
improve the understanding of the underlying mechanisms responsible for SpA 
pathogenesis. Therefore, the following hypotheses have been constructed: 
 
1) Anti-HSP60 antibodies are linked to disease activity in SpA. The aim of this 
study was to investigate if a relationship between antibodies to the immunogenic 
heat shock protein 60 (HSP60) and clinical characteristics exist. Recombinant 
HSP60 was purified for human and 3 different bacteria known to trigger SpA 
disease. Furthermore, an enzyme-linked immunsorbent assay (ELISA) was 
established to determine levels of anti-HSP60 IgG subclass antibodies. 
 
2) IgG subclass determination of the Anti-HSP60 response in SpA does not support 
cross-reactivity. The aim of the second study was to make a cohort study in which 
antibodies were determined over time. Furthermore, The IgG subclass specificity for 
bacterial and human HSP60 was to be investigated in more detail. 
 
3) SNP’s in the IL-1A gene affect kinetics in the IL-1α response. The aim of the 
third study was to investigate the IL-1α kinetics among human monocytes and 
macrophages. Secondly to develop a functional assay to investigate the importance 
of SNP’s in IL-1A for use in a clinical study in which PBMC’s from SpA patient 
collected in study I would serve as donors. 
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